Application 088448
- Type
- ANDA
- Sponsor
- ABRAXIS PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEXAMETHASONE | DEXAMETHASONE SODIUM PHOSPHATE | INJECTABLE;INJECTION | EQ 4MG PHOSPHATE/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A088448-001 | DEXAMETHASONE | DEXAMETHASONE SODIUM PHOSPHATE | EQ 4MG PHOSPHATE/ML | INJECTABLE / INJECTION | 1984-01-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A088448-001 | DEXAMETHASONE | EQ 4MG PHOSPHATE/ML | INJECTABLE / INJECTION | 1984-01-25 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A088448-001 | DEXAMETHASONE | EQ 4MG PHOSPHATE/ML | INJECTABLE / INJECTION | 1984-01-25 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A088448-001 | DEXAMETHASONE | EQ 4MG PHOSPHATE/ML | INJECTABLE / INJECTION | 1984-01-25 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A088448-001 | DEXAMETHASONE | EQ 4MG PHOSPHATE/ML | INJECTABLE / INJECTION | 1984-01-25 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | REMEDYREPACK INC. | 11f10a47-1c42-40e4-89d8-bb000fef497c | 2026-09-09 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone | DEXAMETHASONE | REMEDYREPACK INC. | 8c5375a7-7a0d-4af0-8b86-bc87698ac3d1 | 2026-09-04 | Warnings, Adverse reactions | Dexamethasone |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sportpharm LLC | 9822a5c3-d3f1-4e0b-9963-32b22740e10e | 2026-08-31 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone sodium phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Micro Labs Limited | c6f2563b-5a39-48bf-bcfe-71dd417bd970 | 2026-08-26 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | ASCLEMED USA INC. | a31b013f-924c-42f8-b8ab-ce60bb8ad7b8 | 2026-08-07 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sagent Pharmaceuticals | 4680d517-ed5a-4137-819c-122ee962a464 | 2026-08-06 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone | DEXAMETHASONE | Sportpharm LLC | a37486b9-4323-41fc-ac7e-869d95dc9568 | 2026-07-17 | Warnings, Adverse reactions | Dexamethasone |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sportpharm LLC | a8aee11f-c928-41ef-8df8-e6d8b355536c | 2026-07-10 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone | DEXAMETHASONE | REMEDYREPACK INC. | f5c9b70b-b835-4f3b-9643-0aec50a0d3f2 | 2026-07-07 | Warnings, Adverse reactions | Dexamethasone |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | cca2c160-9188-48e8-9505-49a52388dcb7 | 2026-06-30 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | 7cbd9005-7df2-47ee-adb3-7244c1c69bc3 | 2026-06-30 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone | DEXAMETHASONE | Pangea Pharmaceuticals, LLC | a41e6e26-9ebb-4b06-866e-a24af21c644c | 2026-06-29 | Warnings, Adverse reactions | Dexamethasone |
| Dexamethasone | DEXAMETHASONE | PD-Rx Pharmaceuticals, Inc. | 89e1d458-7caa-430f-9c54-360889899a73 | 2026-06-12 | Warnings, Adverse reactions | Dexamethasone |
| Dexamethasone | DEXAMETHASONE | PD-Rx Pharmaceuticals, Inc. | 736861fa-1df8-4afd-ba4a-dd7d7bffd865 | 2026-06-12 | Warnings, Adverse reactions | Dexamethasone |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | 2b626a48-c7aa-4443-9164-a08ff069ccd1 | 2026-06-08 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc | 79b65fd4-16a5-42e0-b041-61d7bda0a5ff | 2026-06-08 | Warnings, Adverse reactions | Dexamethasone |
| Dexamethasone | DEXAMETHASONE | REMEDYREPACK INC. | 8deaaaf7-3efd-4065-b29f-e5ef038030f8 | 2026-06-01 | Warnings, Adverse reactions | Dexamethasone |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Cardinal Health 107, LLC | 6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71 | 2026-05-29 | Warnings, Adverse reactions | DEXAMETHASONE SODIUM PHOSPHATE |
| Dexamethasone | DEXAMETHASONE | Cardinal Health 107, LLC | bf8acfdb-8dc8-4a69-90b0-33c680c421d6 | 2026-05-15 | Warnings, Adverse reactions | Dexamethasone |
| dexamethasone | DEXAMETHASONE | Cardinal Health 107, LLC | 5622f8d2-1893-441b-8011-fa90c8a63b0b | 2026-05-05 | Warnings, Adverse reactions | dexamethasone |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.